Literature DB >> 24287579

The last intron of the human thrombopoietin gene enhances expression in milk of transgenic mice.

Yan Li1, Mingqian Zhou, Hongwei Zhou, Yunshan Ning.   

Abstract

Introns can enhance gene expression levels. This effect is known as intron-mediated enhancement, which is different from that of enhancers or promoters. In our previous study, under the control of the cytomegalovirus or goat β-casein promoter, the vector containing intron V-TPOcDNA expressed the highest thrombopoietin (TPO) level, whereas the vector containing TPOgDNA expressed the lowest level. In order to verify whether intron V also improves TPO expression in the milk of transgenic mice, rat whey acidic protein promoter was used as regulatory element to construct mammary gland expression vectors including pTPOWA (containing TPOcDNA), pTPOWB (containing intron V-TPOcDNA), and pTPOWC (containing TPOgDNA). These vectors were transfected into HC-11 cells and the supernatants were analyzed at 48 h. The highest TPO level was found in pTPOWB (795 pg/mL) and the lowest level in pTPOWC (193 pg/mL). Then, corresponding vectors were microinjected into fertilized mice zygotes. Transgenic mice were identified by polymerase chain reaction and Southern blot. Enzyme-linked immunosorbent assay was performed to measure TPO levels in the milk of lactating transgenic mice. The highest and lowest TPO levels were found in transgenic mice carrying intron V-TPOcDNA (2,307 pg/mL) and in transgenic mice carrying TPOgDNA (242 pg/mL), respectively. Thus, intron V remarkably improved TPO expression in transgenic mice.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24287579     DOI: 10.1007/s10142-013-0348-x

Source DB:  PubMed          Journal:  Funct Integr Genomics        ISSN: 1438-793X            Impact factor:   3.410


  33 in total

1.  Production of biologically active human protein C in the milk of transgenic mice.

Authors:  W H Velander; R L Page; T Morcöl; C G Russell; R Canseco; J M Young; W N Drohan; F C Gwazdauskas; T D Wilkins; J L Johnson
Journal:  Ann N Y Acad Sci       Date:  1992-10-13       Impact factor: 5.691

2.  Comparison of intron-dependent and intron-independent gene expression.

Authors:  A R Buchman; P Berg
Journal:  Mol Cell Biol       Date:  1988-10       Impact factor: 4.272

3.  Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand.

Authors:  F J de Sauvage; P E Hass; S D Spencer; B E Malloy; A L Gurney; S A Spencer; W C Darbonne; W J Henzel; S C Wong; W J Kuang
Journal:  Nature       Date:  1994-06-16       Impact factor: 49.962

4.  Expression of the thrombopoietin gene in human fetal and neonatal tissues.

Authors:  E M Wolber; C Dame; H Fahnenstich; D Hofmann; P Bartmann; W Jelkmann; J Fandrey
Journal:  Blood       Date:  1999-07-01       Impact factor: 22.113

5.  Thrombopoietin: Biology and Clinical Applications.

Authors: 
Journal:  Oncologist       Date:  1996

6.  Thrombopoietin gene expression in the developing human central nervous system.

Authors:  Christof Dame; Eva Maria Wolber; Patricia Freitag; Dietmar Hofmann; Peter Bartmann; Joachim Fandrey
Journal:  Brain Res Dev Brain Res       Date:  2003-07-12

7.  Thrombopoietin production is inhibited by a translational mechanism.

Authors:  N Ghilardi; A Wiestner; R C Skoda
Journal:  Blood       Date:  1998-12-01       Impact factor: 22.113

8.  Rabbit beta-casein promoter directs secretion of human interleukin-2 into the milk of transgenic rabbits.

Authors:  T A Bühler; T Bruyère; D F Went; G Stranzinger; K Bürki
Journal:  Biotechnology (N Y)       Date:  1990-02

9.  Thrombopoietin, the Mp1 ligand, is essential for full megakaryocyte development.

Authors:  K Kaushansky; V C Broudy; N Lin; M J Jorgensen; J McCarty; N Fox; D Zucker-Franklin; C Lofton-Day
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

10.  Recombinant human megakaryocyte growth and development factor stimulates thrombocytopoiesis in normal nonhuman primates.

Authors:  A M Farese; P Hunt; T Boone; T J MacVittie
Journal:  Blood       Date:  1995-07-01       Impact factor: 22.113

View more
  2 in total

Review 1.  Non-viral therapeutic approaches to ocular diseases: An overview and future directions.

Authors:  Rahel Zulliger; Shannon M Conley; Muna I Naash
Journal:  J Control Release       Date:  2015-10-09       Impact factor: 9.776

2.  Intron V, not intron I of human thrombopoietin, improves expression in the milk of transgenic mice regulated by goat beta-casein promoter.

Authors:  Yan Li; Hu Hao; Mingqian Zhou; Hongwei Zhou; Jianbin Ye; Lijun Ning; Yunshan Ning
Journal:  Sci Rep       Date:  2015-11-03       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.